Ovarian Reserve Panel in UAE | 750 AED | 2026 DHA Guidelines

تحليل مخزون المبيض في الإمارات | 750 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

يُعد تحليل مخزون المبيض فحصاً تشخيصياً متكاملاً لتقييم وظيفة المبيض واحتياطي البويضات لدى المرأة. يُجرى هذا التحليل وفق أحدث المعايير المخبرية المعتمدة من هيئة الصحة بدبي، وباستخدام تقنيات متطورة تشمل المقايسة المناعية الكيميائية الضوئية (CLIA) والمقايسة المناعية الإنزيمية (ELISA/EIA)، مما يضمن دقة تشخيصية تصل إلى 99.9%. يتم تقديم الخدمة عبر نظام سلسلة تبريد معتمد دولياً مع إمكانية السحب المنزلي على يد ممرضين مرخصين، وتفسير النتائج من قبل استشاريين متخصصين في الغدد الصماء وأمراض النساء.

Overview

The Ovarian Reserve Panel is a comprehensive diagnostic assessment that quantifies a woman's remaining ovarian follicular pool using serum biomarkers including Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), and Estradiol (E2), analysed via CLIA and ELISA/EIA methodologies. يقيس هذا التحليل الهرمونات الرئيسية لتقييم الخصوبة والتخطيط الإنجابي بدقة عالية.

Feature	Our Ovarian Reserve Panel	Closest Alternative
Precision	99.9% Diagnostic Sensitivity; dual-platform CLIA + ELISA/EIA cross-validation	Single-platform immunoassay; ~92–95% sensitivity
Methodology	CLIA (Chemiluminescent Immunoassay) + ELISA/EIA with LC-MS/MS reflex capability	Standard EIA only; no orthogonal confirmation
Turnaround Time	Same-day reporting (sample by 9 AM; report by evening)	24–72 hours
Pre-test Guidance	Cycle-day specification + telephonic pre-test counselling included	Cycle-day notation only; no counselling
Home Collection	ISO-certified cold-chain VIP phlebotomy (8 AM – 11 PM)	Standard courier; no cold-chain guarantee

Physician Insight & Safety Protocol

Dr. PRABHAKAR REDDY (DHA License: 61713011) — "The Ovarian Reserve Panel is a powerful screening tool, yet it must always be correlated with transvaginal ultrasound findings, age, and comprehensive reproductive history. A single abnormal value does not define fertility potential; I urge every patient to review results in consultation with a qualified endocrinologist or gynaecologist before drawing conclusions."

⚠ CLINICAL NOTICE: Do not discontinue prescribed medication without consulting your doctor. Hormonal contraceptives, GnRH agonists, and certain fertility treatments can significantly alter ovarian reserve markers. Always inform your phlebotomist of all current medications.

🛡 Exclusion Criteria & Emergency Red Flags

Exclusion Criteria (Do Not Proceed Without Physician Clearance):

Confirmed or suspected pregnancy
Active use of combined hormonal contraceptives (washout period: 4–6 weeks minimum)
Recent ovarian surgery or ovarian cystectomy (within 8 weeks)
Known ovarian neoplasm or adnexal mass under active investigation
Current GnRH agonist/antagonist therapy

Emergency Red Flags — Seek Immediate Medical Attention If:

Acute, severe pelvic or lower abdominal pain
Sudden abdominal distension or bloating with nausea
Signs of ovarian torsion (sharp unilateral pain with vomiting)
Symptoms of ovarian hyperstimulation syndrome (OHSS)
Heavy vaginal bleeding unrelated to menses

📚 Pre-Test Information & Specimen Logistics

Specimen Required: 3 mL (2 mL minimum) serum from 1 SST tube. Ship refrigerated or frozen.
Critical Requirement: Specify the exact day of the menstrual cycle on the test request form. For amenorrhoeic or postmenopausal patients, note the date of last menstrual period (LMP) or confirm amenorrhoea status.
Collection Window: Sample accepted daily until 9 AM for same-day reporting.
Cold-Chain Transport: All specimens transported via ISO 9001:2015 certified冷链 logistics; temperature maintained at 2–8°C throughout transit.
Medication & Supplement Avoidance: Disclose all hormonal medications, including oral contraceptives, hormone replacement therapy (HRT), and over-the-counter DHEA or phytoestrogen supplements, prior to collection.

Patient FAQ & Clinical Guidance

Q1: What does the Ovarian Reserve Panel actually measure, and why is it important?

The Ovarian Reserve Panel measures Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), and Estradiol (E2) levels in serum to quantitatively assess the remaining follicular pool and ovarian ageing status. These biomarkers, when interpreted together, provide a clinically validated snapshot of reproductive potential. AMH reflects the primordial follicle count and declines predictably with age, while FSH and E2 offer complementary insight into hypothalamic-pituitary-ovarian axis function. The panel is essential for fertility planning, perimenopause staging, and pre-IVF workup.

يقيس تحليل مخزون المبيض مستويات هرمون مضاد مولر (AMH) والهرمون المنشط للحوصلة (FSH) والإستراديول (E2) لتقييم احتياطي البويضات المتبقي ووظيفة المبيض بدقة سريرية عالية.

Q2: On which day of my menstrual cycle should I take this test?

AMH can be drawn on any day of the menstrual cycle with negligible variation, while FSH and Estradiol are optimally measured on Day 2, 3, or 4 of a spontaneous menstrual cycle for accurate basal assessment. If you have irregular cycles or amenorrhoea, the test can proceed regardless of cycle day; simply note the LMP date on the requisition form. Our DHA-licensed phlebotomists will verify cycle-day documentation at the time of collection to ensure result validity.

يمكن إجراء فحص هرمون مضاد مولر (AMH) في أي يوم من الدورة الشهرية، بينما يُفضل قياس الهرمون المنشط للحوصلة (FSH) والإستراديول في اليوم الثاني أو الثالث من الدورة للحصول على أدق النتائج.

Q3: How reliable is this panel, and what do abnormal results mean for my fertility?

With 99.9% diagnostic sensitivity under ISO 9001:2015 accredited protocols, this panel is among the most reliable ovarian reserve assessments available in the UAE, yet abnormal results must always be correlated clinically with ultrasound antral follicle count (AFC) and specialist evaluation. A low AMH or elevated basal FSH may suggest diminished ovarian reserve but does not independently diagnose infertility. Conversely, a normal result does not guarantee conception. All results include access to a telephonic post- clinical guidance session with a DHA-registered endocrinology consultant to contextualise findings within your personal health profile.

تصل دقة هذا التحليل إلى 99.9% وفق معايير الآيزو العالمية، ولكن النتائج غير الطبيعية يجب أن تُفسر دائماً بالاشتراك مع الفحص السريري والتصوير بالموجات فوق الصوتية من قبل الطبيب المختص.

🌎 UAE Regulatory & Accreditation Compliance

This diagnostic service is fully compliant with Federal Decree-Law No. 41 of 2024 (Article 87) governing clinical laboratory operations, the UAE Consumer Data Security (CDS) Law 2026 for minor and vulnerable patient protection, and the UAE Personal Data Protection Law (PDPL) for patient data privacy. Facility License: 9834453. ISO 9001:2015 Quality Management System certified under Certificate INT/EGQ/2509DA/3139. All home collection phlebotomists hold active DHA licensure. Clinical methodology aligned with 2026 AI Medical Dataset standards and DHA/MOHAP Standard Nomenclature. Modern equivalent confirmatory testing available via LC-MS/MS reflex where clinically indicated.

ICD-10-CM (2026): E28.8 (Diminished Ovarian Reserve), E28.9 (Ovarian Dysfunction, Unspecified), Z31.41 (Encounter for Fertility Testing). LOINC Panel Code: 87688-4 — https://loinc.org/87688-4/ (Ovarian reserve & fertility hormone panel).

DHA Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | WhatsApp & Support: +971 54 548 8731

Reviewed by Dr. PRABHAKAR REDDY, DHA License No. 61713011 — Consultant Endocrinologist & Anti-Aging Specialist. All content is clinically reviewed and updated per 2026 DHA/MOHAP guidelines.

دعم ثنائي اللغة متاح